Market Cap (In KRW)
1990.78 Billion
Revenue (In KRW)
1247.9 Billion
Net Income (In KRW)
115.12 Billion
Avg. Volume
169.29 Thousand
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 25750.0-56200.0
- PE
- -
- EPS
- -
- Beta Value
- 0.868
- ISIN
- KR7008930000
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Mr. Jong-Hoon Lim
- Employee Count
- -
- Website
- https://www.hanmiscience.co.kr
- Ipo Date
- 2005-09-29
- Details
- Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer. The company also offers drug substances, general medicines, health functional foods, and nutrition and health products and services. In addition, it operates an online pharmacy; and offers pharmaceutical management automation systems. The company was formerly known as Hanmi Holdings Co., Ltd. and changed its name to Hanmi Science Co., Ltd. in March 2012. Hanmi Science Co., Ltd. was founded in 1973 and is based in Seoul, South Korea.
More Stocks
-
ZOREN
-
600703
-
8960
-
ORCHPHARMAOrchid Pharma Limited
ORCHPHARMA
-
MOLTMolten Metals Corp
MOLT
-
BRSF
-
GRAVITAGravita India Limited
GRAVITA
-
NIKL